And critically, it acts on the hypothalamus to reduce appetite, creating powerful satiety signals that make people eat significantly less without feeling deprived
It is important for patients and practitioners to understand that 'investigational' or 'research' status does not equate to safety, efficacy, or regulatory approval for human use outside of controlled clinical trial settings
Clear methods reduce confusion during injection preparation tasks within busy labs
GHK-Cu in systemic form (injection, research) has not been registered as a medicinal product in the EU, the USA or anywhere in the world
Peptide Therapy GHK-Cu: COPPER PEPTIDE THERAPY A naturally occurring peptide that declines with age
Each component is studied for a different layer of the regenerative cycle: GHK-Cu for copper-mediated extracellular-matrix and collagen signaling, BPC-157 for angiogenic and growth-factor pathways, and TB-500 (acetylated Thymosin Beta-4) for actin-driven cell migration